MSD obtains a Non-Exclusive License for Cyprumed’s delivery technology to develop oral peptide therapeuticsCyprumed will be eligible to receive up to $493…Read More
You might also be interested in reading House Republican tax bill favors the rich — how much they stand to gain, and why.
